Market Introduction
Typhoid is an infectious disease caused by Salmonella Typhi, through ingestion of contaminated food and water. This intense illness is identified by prolonged fever, headache and nausea, loss of appetite and constipation or sometimes diarrhea. Increasing threats of typhoid and growing threats of drug resistance has helped typhoid vaccines to boost its market especially among rural and hard-to-reach communities where progress in medical services, infrastructure and development may be slow.
Market Overview and Dynamics
The Europe typhoid fever vaccines market is expected to reach US$ 145.36 million in 2027 from US$ 74.43 million in 2019. The market is estimated to grow with a CAGR of 9.0% from 2020-2027. Factors such as increase in number of EU citizens travelling outside Europe and presence of market players in the European region is likely to contribute to the growth of the market. On the other hand, the market is likely to have negative impact due to risk of associated with typhoid fever vaccines.
Key Market Segments
On the basis of vaccine type, the typhoid fever vaccines market has been segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR in the market during the forecast period. Global typhoid fever vaccines market based on route of administration is segmented into oral and injectable. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR in the market during the forecast period
Major Sources and Companies Listed
Some of the major secondary sources for Europe typhoid fever vaccines market included in the report are, Spanish National Health System, International Trade Administration, World Health Organization and others.
Reasons to buy the report
- To understand the Europe typhoid fever vaccines market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe typhoid fever vaccines market
- Efficiently plan M&A and partnership deals in Europe typhoid fever vaccines market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe typhoid fever vaccines market
- Obtain market revenue forecast for market by various segments from 2019-2027 in Europe.
Europe Typhoid Fever Vaccines Market –
By Vaccine Type
- Live Attenuated Vaccine
- Capsular Polysaccharide Vaccines
- Conjugate Vaccine
- Others
By Route of Administration
- Oral
- Injectable
- Spain
- Italy
- UK
- Germany
- France
Company Profiles
- Sanofi
- GlaxoSmithKline plc
- Paxvax Inc
- Prokarium Ltd
- Scandinavian Biopharma